Drug Testers Are Panicking Over Potential Federal Rescheduling as Trump Weighs Next Move

The drug testing industry is currently in a panic as reports suggest President Trump might be ready to sign an executive order moving cannabis to Schedule III. The National Drug & Alcohol Screening Association (NDASA) is sounding the alarm, claiming that reclassification could create a "loophole" allowing transportation workers like pilots and truckers to skip mandatory drug tests. They are even hosting webinars and recruiting members of Congress to fight the move, clinging to old-school prohibition-era arguments about workplace safety.

While these groups focus on keeping the "guardrails" of the 80s alive, the reality is that Schedule III would finally acknowledge the medical benefits of the plant and fix outdated federal policies. For regular tokers, this matters because it represents a massive shift away from treating cannabis like heroin. While corporate drug testers are worried about their bottom line, rescheduling is a huge step toward ending the stigma for workers who use cannabis responsibly off the clock. It’s a sign that the federal government is finally catching up to the community, despite the noise from the opposition.